International Journal of
Reproductive Biomedicine
Wed, Apr 24, 2024
[Archive]
Volume 10, Issue 5 (10-2012)
IJRM 2012, 10(5): 489-492 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Yassaee F, Eskandari R, Amiri Z. Pregnancy outcomes in women with idiopathic thrombocytopenic purpura. IJRM 2012; 10 (5) :489-492
URL: http://ijrm.ir/article-1-308-en.html
URL: http://ijrm.ir/article-1-308-en.html
1- Department of Obstetrics and Gynecology, Genomic Research Center, Shahid Beheshti University of Medical Sciences, Taleghani Hospital, Tehran, Iran , dr_fyass@yahoo.com
2- Department of Obstetrics and Gynecology, Shahid Beheshti University of Medical Sciences, Taleghani Hospital, Tehran, Iran
3- Department of Basic Sciences, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2- Department of Obstetrics and Gynecology, Shahid Beheshti University of Medical Sciences, Taleghani Hospital, Tehran, Iran
3- Department of Basic Sciences, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract: (4119 Views)
Background: Idiopathic thrombocytopenic purpura (ITP) is a disease that commonly affects women of reproductive age and is associated with maternal and fetal complications.
Objective: The aim of the present study was to report the perinatal outcome in pregnant women with ITP. Materials and Methods: Twenty one pregnant women with ITP admitted in a teaching hospital in Tehran, from October 2008 to February 2010, were enrolled in this prospective historical cohort study; course and perinatal outcome of pregnancies were studied.
Results: Seven (33.3%) cases had been diagnosed before pregnancy, while the other fourteen (66.7%) were diagnosed during pregnancy. During hospitalization, thirteen (62%) patients required treatment, eight (61.5%) of them with steroids, two (15.3%) received intravenous immunoglobulin (IVIG), and three (23%) were treated with steroids and IVIG. Three babies were delivered vaginally (14.3%), seventeen (81%) through cesarean section and one patient aborted her fetus. Nine mothers (42.9%) had platelet counts <50000/ml at the time of delivery; but postpartum hemorrhage occurred in 4 (19%) women and one women received platelet transfusion during cesarean section. Six (28.6%) women developed gestational diabetes. Pregnancy was complicated by preeclampsia in one woman and by abruptio placenta in another. One pregnancy terminated in intrauterine fetal death. Seventeen infants (89.5%) had normal platelet counts, and two (10.5%) had moderate thrombocytopenia. No infant showed signs of hemorrhage, but 2 neonates (10.5%) were diagnosed with intrauterine growth restriction.
Conclusion: Rate of gestational diabetes in pregnant women with ITP is higher than the general population. Rate of gestinational diabetes is 3-5% and postpartum hemorrhage is 5-7% in general. Postpartum hemorrhage is common in these women. Severe thrombocytopenia and bleeding in the newborns are uncommon.
Objective: The aim of the present study was to report the perinatal outcome in pregnant women with ITP. Materials and Methods: Twenty one pregnant women with ITP admitted in a teaching hospital in Tehran, from October 2008 to February 2010, were enrolled in this prospective historical cohort study; course and perinatal outcome of pregnancies were studied.
Results: Seven (33.3%) cases had been diagnosed before pregnancy, while the other fourteen (66.7%) were diagnosed during pregnancy. During hospitalization, thirteen (62%) patients required treatment, eight (61.5%) of them with steroids, two (15.3%) received intravenous immunoglobulin (IVIG), and three (23%) were treated with steroids and IVIG. Three babies were delivered vaginally (14.3%), seventeen (81%) through cesarean section and one patient aborted her fetus. Nine mothers (42.9%) had platelet counts <50000/ml at the time of delivery; but postpartum hemorrhage occurred in 4 (19%) women and one women received platelet transfusion during cesarean section. Six (28.6%) women developed gestational diabetes. Pregnancy was complicated by preeclampsia in one woman and by abruptio placenta in another. One pregnancy terminated in intrauterine fetal death. Seventeen infants (89.5%) had normal platelet counts, and two (10.5%) had moderate thrombocytopenia. No infant showed signs of hemorrhage, but 2 neonates (10.5%) were diagnosed with intrauterine growth restriction.
Conclusion: Rate of gestational diabetes in pregnant women with ITP is higher than the general population. Rate of gestinational diabetes is 3-5% and postpartum hemorrhage is 5-7% in general. Postpartum hemorrhage is common in these women. Severe thrombocytopenia and bleeding in the newborns are uncommon.
Type of Study: Original Article |
References
1. Vera EV, Gonzales-Quintero VH. Thrombocytopenia in pregnancy. Available at: http://emedicine. medscape.com/article/272867-overview.
2. Wang Q, Nie LL. Clinical analysis of 92 cases of pregnancy with idiopathic thrombocytopenic purpura. Zhonghua Fu chan Ke Za Zhi 2004; 39: 729-732.
3. Ali R, Ozkalemkas F, Ozcelik T, Ozkocaman V, O zan U, Kimya Y, et al. Thrombocytopenic purpura in pregnancy: a single institutional experience with maternal and neonatal outcomes. Ann Hematol 2003: 82: 348-352. [DOI:10.1007/s00277-003-0665-6]
4. Hwa HL, Chen RJ, Chen YC, Wang TR, Haunq SC, Chow SN. Maternal and fetal outcome of pregnant women with idiopathic thrombocytopenic purpura: retrospective analysis of 25 pregnancies. J Formos Med Assoc 1993; 92: 957-961.
5. Al-Jama FE, Rahman J, Al-Suleiman SA, Rahman MS. Outcome of pregnancy in women with idiopathic thrombocytopenic purpura. Aust N Z J Obstet Gynecol 1998; 38: 410-413. [DOI:10.1111/j.1479-828X.1998.tb03099.x]
6. Peleg D, Hunter Sk. Perinatal management of women with immune thrombocytopenic purpura:survey of united state perinatologists. Am J Obstet Gynecol 1999; 180: 645-649. [DOI:10.1016/S0002-9378(99)70286-3]
7. Sainio S, Joutsi L, Järvenpää AL, Kekomäki R, Koistinen E, Riikonen S, et al. Idiopathic thrombocytopenic purpura in pregnancy. Acta Obstet Gynecol Scand 1998; 77: 272-277 [DOI:10.1080/j.1600-0412.1998.770303.x]
8. Gill KK, Kelton JG. Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol 2000; 37: 275-289 [DOI:10.1016/S0037-1963(00)90106-9]
9. Lee MS, Kim WC. Intracranial hemorrhage associated with idiopathic thrombocytopenic purpura: report of seven patients and a meta-analysis. Neurology 1998; 50: 1160-1163. [DOI:10.1212/WNL.50.4.1160]
10. Nisaratanaporn S, Sukcharoen N. Outcome of idiopathic thrombocytopenic purpura in pregnancy in King chulalongkorn Memorial Hospital. J Med Assoc Thai 2006; 89: 70-75.
11. Won YW, Moon W, Yun YS, Oh HS, Choi JH, Lee YY, et al. Clinical aspects of pregnancy and delivery in patients with chronic idiopathic thrombocytopenic purpura (ITP). Korean J Intern Med 2005; 20: 129-134. [DOI:10.3904/kjim.2005.20.2.129]
12. Sukenik-Halevy R, Ellis MH, Fejgin MD. Management of immune thrombocytopenic pupura in pregnancy. Obstet Gynecol Surv 2008; 63: 182-188. [DOI:10.1097/OGX.0b013e318164013c]
13. Belkin A, Levy A, Sheiner E. Perinatal outcomes and complications of pregnancy in women with immune thrombocytopenic purpura. J Matern Fetal Neonatal Med 2009; 22: 1081-1085 [DOI:10.3109/14767050903029592]
14. Ozkan H, Cetinkaya M, Köksal N, Ali R, Güneş AM, Baytan B, et al. Neonatal outcomes of pregnancy Complicated by idiopathic thrombocytopenic purpura. J Perinatol 2010; 30: 38-44. [DOI:10.1038/jp.2009.134]
15. Suri V, Aggarwal N, Saxena S, Malhotra P, Varma S. Maternal and perinatal outcome in idiopathic thrombocytopenic purpura (ITP) with pregnancy. Acta obstet Gynecol scand 2006; 85: 1430-1435. [DOI:10.1080/00016340600961116]
16. Devendra K, Koh LP. Pregnancy in women with idiopathic thrombocytopenic Purpura. Ann Acad Med Singapore 2002; 31: 276-280.
17. Johnson JR, Samuels P. Review of autoimmune thrombocytopenia, pathogenesis, diagnosis, and management in pregnancy. Clin Obstet Gynecol 1999; 42: 317-326. [DOI:10.1097/00003081-199906000-00016]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
